Comparative Effectiveness Funding
The Recovery Act (ARRA) contains $1.1 billion for comparative effectiveness research. Comparative effectiveness research (CER) compares treatments and strategies to improve health. This information is essential for clinicians and patients to decide on the best treatment. It also enables our nation to improve the health of communities and the performance of the health system.
These funds are to support research assessing the comparative effectiveness of health care treatments and strategies, through efforts that:
ARRA also created the Federal Coordinating Council for Comparative Effectiveness Research to coordinate comparative effectiveness research across the Federal government. The Council will specifically make recommendations for the $400 million allocated to the Office of the Secretary for CER. The Council will include one senior officer or employee from each of the following agencies:
Read the excerpt from the Recovery Act related to comparative effectiveness research.